阿斯利康在中国“买买买”的节奏并没有停下来。3月21日晚间,和铂医药(02142.HK)发布公告称,公司拟向阿斯利康配发及发行认购股份,后者将以每股1.38美元(相当于每股约10.74港元)的价格进行认购。3月21日当天,和铂医药港股股价每股报7.83港元,这次的发行价相当于溢价37%。本次阿斯利康认购的股份,将占和铂医药新发行股份的9.15%。和铂医药方面表示,认购所得款项约为1.05亿美元(约...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.